Esophageal Cancer
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2006; 12(46): 7472-7477
Published online Dec 14, 2006. doi: 10.3748/wjg.v12.i46.7472
Figure 1
Figure 1 RT-PCR analysis of the effect of siRNA-expressing vector on Bcl-XL gene expression. A: Argarose gel electrophoresis of the RT-PCR products. L1: DNA marker; L2: RT-PCR product of the untreated cells; L3: RT-PCR product of the empty pTZ-U6+1 vector treated cells; L4: RT-PCR product of the control siRNA-expressing vector treated cells; L5: RT-PCR product of the siRNA-expressing vector No.1 treated cells; L6: RT-PCR product of the siRNA-expressing vector No.2 treated cells; L7: RT-PCR product of the siRNA-expressing vector No.3 treated cells. B: Quantification of the RT-PCR products (mean ± SD, n = 3, aP < 0.05 vs untreated esophageal cancer cells).